Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Receivables: 2009-2025

Historic Receivables for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $22.1 million.

  • Lifecore Biomedical's Receivables rose 8.78% to $22.1 million in Q2 2025 from the same period last year, while for May 2025 it was $110.9 million, marking a year-over-year increase of 29.80%. This contributed to the annual value of $22.1 million for FY2025, which is 8.78% up from last year.
  • As of FY2025, Lifecore Biomedical's Receivables stood at $22.1 million, which was up 8.78% from $20.3 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Receivables registered a high of $49.2 million during FY2022, and its lowest value of $20.3 million during FY2024.
  • For the 3-year period, Lifecore Biomedical's Receivables averaged around $25.1 million, with its median value being $22.1 million (2025).
  • Per our database at Business Quant, Lifecore Biomedical's Receivables plummeted by 50.48% in 2021 and then grew by 16.70% in 2022.
  • Over the past 5 years, Lifecore Biomedical's Receivables (Yearly) stood at $42.2 million in 2021, then grew by 16.70% to $49.2 million in 2022, then slumped by 33.57% to $32.7 million in 2023, then tumbled by 37.80% to $20.3 million in 2024, then grew by 8.78% to $22.1 million in 2025.